235 related articles for article (PubMed ID: 25710580)
21. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
22. Acute Myeloid Leukemia (AML): Upregulation of BAALC/MN1/MLLT11/EVI1 Gene Cluster Relate With Poor Overall Survival and a Possible Linkage With Coexpression of MYC/BCL2 Proteins.
Akhter A; Farooq F; Elyamany G; Mughal MK; Rashid-Kolvear F; Shabani-Rad MT; Street L; Mansoor A
Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):483-488. PubMed ID: 28362701
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
24. Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients.
Bacher U; Kern W; Schnittger S; Hiddemann W; Schoch C; Haferlach T
Ann Hematol; 2005 Nov; 84(12):785-91. PubMed ID: 16132906
[TBL] [Abstract][Full Text] [Related]
25. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
[TBL] [Abstract][Full Text] [Related]
26. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
[TBL] [Abstract][Full Text] [Related]
27. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukaemia: expression of MYC protein and its association with cytogenetic risk profile and overall survival.
Mughal MK; Akhter A; Street L; Pournazari P; Shabani-Rad MT; Mansoor A
Hematol Oncol; 2017 Sep; 35(3):350-356. PubMed ID: 26856970
[TBL] [Abstract][Full Text] [Related]
30. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
[TBL] [Abstract][Full Text] [Related]
31. Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis.
Graf M; Reif S; Kröll T; Hecht K; Nuessler V; Schmetzer H
Am J Hematol; 2006 Apr; 81(4):227-35. PubMed ID: 16550517
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.
Preiss BS; Bergmann OJ; Friis LS; Sørensen AG; Frederiksen M; Gadeberg OV; Mourits-Andersen T; Oestergaard B; Kerndrup GB;
Cancer Genet Cytogenet; 2010 Oct; 202(2):108-22. PubMed ID: 20875873
[TBL] [Abstract][Full Text] [Related]
33. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
34. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
Schaich M; Illmer T; Seitz G; Mohr B; Schäkel U; Beck JF; Ehninger G
Haematologica; 2001 May; 86(5):470-7. PubMed ID: 11410409
[TBL] [Abstract][Full Text] [Related]
35. [Expression of microRNA-223 in lymphocytic leukemia cells and its action mechanism].
Nan Z; Liang Y; Fu R; Liu H; Ruan EB; Wang XM; Wang GJ; Qu W; Liu H; Wu YH; Song J; Xing LM; Guan J; Li LJ; Wang HQ; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):556-61. PubMed ID: 23815897
[TBL] [Abstract][Full Text] [Related]
36. Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia.
Butrym A; Łacina P; Kuliczkowski K; Bogunia-Kubik K; Mazur G
BMC Cancer; 2018 Jan; 18(1):107. PubMed ID: 29382303
[TBL] [Abstract][Full Text] [Related]
37. Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.
Schwartz S; Heinecke A; Zimmermann M; Creutzig U; Schoch C; Harbott J; Fonatsch C; Löffler H; Büchner T; Ludwig WD; Thiel E
Leuk Lymphoma; 1999 Jun; 34(1-2):85-94. PubMed ID: 10350335
[TBL] [Abstract][Full Text] [Related]
38. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.
Rücker FG; Russ AC; Cocciardi S; Kett H; Schlenk RF; Botzenhardt U; Langer C; Krauter J; Fröhling S; Schlegelberger B; Ganser A; Lichter P; Zenz T; Döhner H; Döhner K; Bullinger L
Leukemia; 2013 Feb; 27(2):353-61. PubMed ID: 22810507
[TBL] [Abstract][Full Text] [Related]
39. Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy.
Wetzler M; Baer MR; Bernstein SH; Blumenson L; Stewart C; Barcos M; Mrózek K; Block AW; Herzig GP; Bloomfield CD
J Clin Oncol; 1997 Jun; 15(6):2262-8. PubMed ID: 9196139
[TBL] [Abstract][Full Text] [Related]
40. XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis.
Tamm I; Richter S; Scholz F; Schmelz K; Oltersdorf D; Karawajew L; Schoch C; Haferlach T; Ludwig WD; Wuchter C
Hematol J; 2004; 5(6):489-95. PubMed ID: 15570290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]